Wojciech Madej

571 citations
15 papers · 448 indexed · h-index 11
Topics
TGF-β signaling in diseases (8 papers)Osteoarthritis Treatment and Mechanisms (8 papers)Inflammatory mediators and NSAID effects (4 papers)

In The Last Decade

Wojciech Madej

15 papers receiving 443 citations

Peers

Wojciech Madej
Comparison fields: 5 of 78
  • Rheumatology 194
  • Biomedical Engineering 147
  • Surgery 123
  • Molecular Biology 121
  • Biomaterials 52
Replace Sabine Loty with:
Sabine Loty France
Seung‐Ki Min South Korea
S.R. Goldring United States
K‐L. Paul Sung United States
Jordan D. Skelly United States
Sleiman Razzouk United States
Helena Bacha Lopes Brazil
Jan Lassus Finland
Wen-Fu T. Lai Taiwan
Kouki Hatori Japan
Wojciech Madej relative to Sabine Loty France Sabine Loty's profile →
Citations per field
00.5×10×15.3×
Sabine Loty · 1×
Citations per year

Countries citing papers authored by Wojciech Madej

Since Specialization
Citations

This map shows the geographic impact of Wojciech Madej's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wojciech Madej with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wojciech Madej more than expected).

Fields of papers citing papers by Wojciech Madej

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wojciech Madej. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wojciech Madej. The network helps show where Wojciech Madej may publish in the future.

Co-authorship network of co-authors of Wojciech Madej

This figure shows the co-authorship network connecting the top 25 collaborators of Wojciech Madej. A scholar is included among the top collaborators of Wojciech Madej based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wojciech Madej. Wojciech Madej is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 50
3 17
4 31
5 17
6 35
7 43
8 4
9 32
10 51
11 1
12 77
13 8
14 31
15 49

About Wojciech Madej

Wojciech Madej is a scholar working on Rheumatology, Immunology and Allergy and Pharmacology, having authored 15 papers that have together received 448 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (8 papers), Osteoarthritis Treatment and Mechanisms (8 papers) and Inflammatory mediators and NSAID effects (4 papers). The work is most often cited by research in Rheumatology (194 citations), Immunology and Allergy (36 citations) and Oral Surgery (38 citations). Wojciech Madej has collaborated with scholars based in Netherlands, Poland and United States. Frequent co-authors include Pieter Buma, A. van Caam, P.M. van der Kraan, E.N. Blaney Davidson, Gerjon Hannink, Peter van der Kraan, Anna M. Osyczka, Łukasz Niedźwiedzki, Jakub Rysz and Joanna Raczkowska. Their work appears in journals such as PLoS ONE, Langmuir and The American Journal of Sports Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026